Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate of $(0.87) by 41.38 percent. This is a 29.31 percent increase over losses of $(1.74) per share from the same period last year. The company reported quarterly sales of $1.454 million which beat the analyst consensus estimate of $1.348 million by 7.88 percent. This is a 1.39 percent increase over sales of $1.434 million the same period last year.